Everyday Health on MSN
How Crohn’s Disease Affects Your Skin
Some of the rarer skin conditions associated with Crohns disease include acrodermatitis enteropathica and epidermolysis ...
A large review of the available evidence shows that ultra-processed food consumption is linked to no fewer than 12 major ...
Ultraprocessed foods are also often high in added sugars (which have been linked to greater risks of colorectal cancer and ...
Researchers said a study of more than 66,000 U.S. adults found heavy drinkers who also used cannabis were less likely to ...
AleraCare, a leading provider of infusion and specialty pharmacy services across the U.S., and Pure Healthcare, a leading national medical group that delivers healthcare services for individuals with ...
This new IP supports crofelemer's global exclusivity in rare pediatric intestinal failure coincident with published clinical ...
AleraCare, which is backed by Hildred Capital Partners, has merged with Pure Healthcare, a Utah-based provider of healthcare ...
Next generation weight loss drugs are prohibitively expensive for many in the US who would benefit from taking them—and may remain so, thanks to the phenomenon of patent thickets. Paige Huffman ...
Amorphical, developer of nano-amorphous mineral-based pharmacologic agents for health conditions, today announced that the first patient has been enrolled in its Phase 2 clinical trial evaluating the ...
HKeyBio, a global leading CRO specializing in preclinical and translational research for autoimmune and allergic disease drug development, has officially launched the upgraded HKEY-AIDMD 3.0 platform.
Inflammatory bowel disease (IBD) in children and adolescents represents a rapidly growing field of research within pediatric gastroenterology. Over the past ...
TipRanks on MSN
Abivax initiated with a Buy at Truist
Truist analyst Gregory Renza initiated coverage of Abivax (ABVX) with a Buy rating and $140 price target Following a second-half re-rate from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results